LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA – Alnylam Pharmaceuticals, Inc. Transaction History
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA portfolio value:
$393,000
portfolio value
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 106K | $200.16 | 1.96K | |
| Q2 2022 | share | Decrease | -2.96% | -60 shares | -44K | $145.85 | 1.96K |
| Q1 2022 | share | 0.00% | 0 shares | -12K | $163.29 | 2.02K | |
| Q4 2021 | share | 0.00% | 0 shares | -39K | $171.03 | 2.02K | |
| Q3 2021 | share | Decrease | -0.83% | -17 shares | 36K | $188.81 | 2.02K |
| Q2 2021 | share | Decrease | -0.24% | -5 shares | 57K | $169.52 | 2.04K |
| Q1 2021 | share | Increase | +1.09% | 22 shares | 26K | $141.19 | 2.04K |
| Q4 2020 | share | 0.00% | 0 shares | -32K | $129.97 | 2.02K | |
| Q3 2020 | share | 0.00% | 0 shares | -5K | $145.6 | 2.02K | |
| Q2 2020 | share | 0.00% | 0 shares | 80K | $148.11 | 2.02K | |
| Q1 2020 | share | 0.00% | 0 shares | -13K | $108.85 | 2.02K | |
| Q4 2019 | share | 0.00% | 0 shares | 70K | $115.17 | 2.02K | |
| Q3 2019 | share | 0.00% | 0 shares | 16K | $80.42 | 2.02K | |
| Q2 2019 | share | 0.00% | 0 shares | -42K | $72.56 | 2.02K | |
| Q1 2019 | share | 0.00% | 0 shares | 41K | $93.45 | 2.02K | |
| Q4 2018 | share | Decrease | -74.78% | -6.00K shares | -555K | $72.91 | 2.02K |
| Q3 2018 | share | 0.00% | 0 shares | -88K | $87.52 | 8.03K | |
| Q2 2018 | share | 0.00% | 0 shares | -165K | $98.49 | 8.03K | |
| Q1 2018 | share | 0.00% | 0 shares | -64K | $119.1 | 8.03K | |
| Q4 2017 | share | Decrease | -2.96% | -245 shares | 48K | $127.05 | 8.03K |
| Q3 2017 | share | 0.00% | 0 shares | 287K | $117.49 | 8.27K | |
| Q2 2017 | share | 0.00% | 0 shares | 261K | $79.76 | 8.27K | |
| Q1 2017 | share | 0.00% | 0 shares | 114K | $51.25 | 8.27K | |
| Q4 2016 | share | 0.00% | 0 shares | -251K | $37.44 | 8.27K | |
| Q3 2016 | share | Decrease | -3.67% | -315 shares | 84K | $67.78 | 8.27K |
| Q2 2016 | share | 0.00% | 0 shares | -62K | $55.49 | 8.59K | |
| Q1 2016 | share | 0.00% | 0 shares | -270K | $62.77 | 8.59K |